ALT level was significantly higher (P < 0.0001) in the MetS cases with COVID-19 (40.3 ± 10.6 IU/L) compared to MetS cases without COVID-19 infection (25.7 ± 6.9 IU/L). The gene discussed is GPT; the disease is metabolic syndrome.